62 related articles for article (PubMed ID: 19734843)
1. The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression.
Subhawong AP; Heaphy CM; Argani P; Konishi Y; Kouprina N; Nassar H; Vang R; Meeker AK
Mod Pathol; 2009 Nov; 22(11):1423-31. PubMed ID: 19734843
[TBL] [Abstract][Full Text] [Related]
2. Visualization of Telomere Integrity and Function In Vitro and In Vivo Using Immunofluorescence Techniques.
Cesare AJ; Heaphy CM; O'Sullivan RJ
Curr Protoc Cytom; 2015 Jul; 73():12.40.1-12.40.31. PubMed ID: 26132175
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Heaphy CM; Subhawong AP; Hong SM; Goggins MG; Montgomery EA; Gabrielson E; Netto GJ; Epstein JI; Lotan TL; Westra WH; Shih IeM; Iacobuzio-Donahue CA; Maitra A; Li QK; Eberhart CG; Taube JM; Rakheja D; Kurman RJ; Wu TC; Roden RB; Argani P; De Marzo AM; Terracciano L; Torbenson M; Meeker AK
Am J Pathol; 2011 Oct; 179(4):1608-15. PubMed ID: 21888887
[TBL] [Abstract][Full Text] [Related]
4. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas.
Nguyen DN; Heaphy CM; de Wilde RF; Orr BA; Odia Y; Eberhart CG; Meeker AK; Rodriguez FJ
Brain Pathol; 2013 May; 23(3):237-43. PubMed ID: 22928601
[TBL] [Abstract][Full Text] [Related]
5. The co-expression of telomerase and ALT pathway in human breast cancer tissues.
Xu B; Peng M; Song Q
Tumour Biol; 2014 May; 35(5):4087-93. PubMed ID: 24375252
[TBL] [Abstract][Full Text] [Related]
6. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
[TBL] [Abstract][Full Text] [Related]
7. Visualization and quantitative analysis of extrachromosomal telomere-repeat DNA in individual human cells by Halo-FISH.
Komosa M; Root H; Meyn MS
Nucleic Acids Res; 2015 Feb; 43(4):2152-63. PubMed ID: 25662602
[TBL] [Abstract][Full Text] [Related]
8. Interchromosomal homology searches drive directional ALT telomere movement and synapsis.
Cho NW; Dilley RL; Lampson MA; Greenberg RA
Cell; 2014 Sep; 159(1):108-121. PubMed ID: 25259924
[TBL] [Abstract][Full Text] [Related]
9. Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Vinagre J; Pinto V; Celestino R; Reis M; Pópulo H; Boaventura P; Melo M; Catarino T; Lima J; Lopes JM; Máximo V; Sobrinho-Simões M; Soares P
Virchows Arch; 2014 Aug; 465(2):119-33. PubMed ID: 25048572
[TBL] [Abstract][Full Text] [Related]
10. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.
Jiao Y; Killela PJ; Reitman ZJ; Rasheed AB; Heaphy CM; de Wilde RF; Rodriguez FJ; Rosemberg S; Oba-Shinjo SM; Nagahashi Marie SK; Bettegowda C; Agrawal N; Lipp E; Pirozzi C; Lopez G; He Y; Friedman H; Friedman AH; Riggins GJ; Holdhoff M; Burger P; McLendon R; Bigner DD; Vogelstein B; Meeker AK; Kinzler KW; Papadopoulos N; Diaz LA; Yan H
Oncotarget; 2012 Jul; 3(7):709-22. PubMed ID: 22869205
[TBL] [Abstract][Full Text] [Related]
11. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.
de Wilde RF; Heaphy CM; Maitra A; Meeker AK; Edil BH; Wolfgang CL; Ellison TA; Schulick RD; Molenaar IQ; Valk GD; Vriens MR; Borel Rinkes IH; Offerhaus GJ; Hruban RH; Matsukuma KE
Mod Pathol; 2012 Jul; 25(7):1033-9. PubMed ID: 22575867
[TBL] [Abstract][Full Text] [Related]
12. Altered telomeres in tumors with ATRX and DAXX mutations.
Heaphy CM; de Wilde RF; Jiao Y; Klein AP; Edil BH; Shi C; Bettegowda C; Rodriguez FJ; Eberhart CG; Hebbar S; Offerhaus GJ; McLendon R; Rasheed BA; He Y; Yan H; Bigner DD; Oba-Shinjo SM; Marie SK; Riggins GJ; Kinzler KW; Vogelstein B; Hruban RH; Maitra A; Papadopoulos N; Meeker AK
Science; 2011 Jul; 333(6041):425. PubMed ID: 21719641
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions.
Cesare AJ; Kaul Z; Cohen SB; Napier CE; Pickett HA; Neumann AA; Reddel RR
Nat Struct Mol Biol; 2009 Dec; 16(12):1244-51. PubMed ID: 19935685
[TBL] [Abstract][Full Text] [Related]
14. Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.
Dogeas E; Karagkounis G; Heaphy CM; Hirose K; Pawlik TM; Wolfgang CL; Meeker A; Hruban RH; Cameron JL; Choti MA
J Am Coll Surg; 2014 Apr; 218(4):628-35. PubMed ID: 24655849
[TBL] [Abstract][Full Text] [Related]
15. The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT).
Sohn EJ; Goralsky JA; Shay JW; Min J
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046606
[TBL] [Abstract][Full Text] [Related]
16. Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT).
Sun H; Chen G; Guo B; Lv S; Yuan G
J Cancer; 2023; 14(3):417-433. PubMed ID: 36860927
[TBL] [Abstract][Full Text] [Related]
17. Reprint of: The Diagnostic and Prognostic Utility of Incorporating DAXX, ATRX, and Alternative Lengthening of Telomeres (ALT) to the Evaluation of Pancreatic Neuroendocrine Tumors (PanNETs).
Heaphy CM; Singhi AD
Hum Pathol; 2023 Feb; 132():1-11. PubMed ID: 36702689
[TBL] [Abstract][Full Text] [Related]
18. THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
Apolónio JD; Dias JS; Fernandes MT; Komosa M; Lipman T; Zhang CH; Leão R; Lee D; Nunes NM; Maia AT; Morera JL; Vicioso L; Tabori U; Castelo-Branco P
Clin Epigenetics; 2022 Dec; 14(1):178. PubMed ID: 36529814
[TBL] [Abstract][Full Text] [Related]
19. Alternative lengthening of telomeres in primary hepatic neoplasms.
Yasir S; Thompson S; Chen ZE; Knudson R; Knutson D; Kloft-Nelson S; Graham RP; Jain D; Simon SM; Wu TT; Torbenson M
Hum Pathol; 2023 Jan; 131():79-86. PubMed ID: 36370823
[TBL] [Abstract][Full Text] [Related]
20. Telomerase in Cancer: Function, Regulation, and Clinical Translation.
Robinson NJ; Schiemann WP
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
